Clinical Trial

The Effect of Vitamin D Supplementation on the Anti-inflammatory Response in Periodontal Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
A review of the literature revealed that while there are studies investigating the relationship between vitamin D and periodontal disease, there are no studies investigating the anti-inflammatory effect of vitamin D on periodontal disease. Investigators hypothesized that the increased incidence of periodontal disease in individuals with vitamin D deficiency might be due not only to pro-inflammatory effects but also to impaired bone metabolism and a decrease in the anti- inflammatory mechanism. Investigators aimed to determine this by comparing serum and DOS levels of 1,25-dihydroxyvitamin D (1,25(OH)2D), 25-hydroxyvitamin D (25(OH)D3), Receptor activator nuclear kappa B ligand (RANKL), osteoprotegerin (OPG), Tumor Necrosis Factor Related Apoptosis induced Ligand (TRAIL), Developmental endothelial locus (Del)-1, Lipoxin, Resolvin, interleukin (IL)-10, and transforming growth factor-β (TGF-β). The study will include 120 individuals who are systemically healthy based on clinical and radiographic examinations and diagnosed with Stage I-II periodontitis, Stage III-IV periodontitis, chronic gingivitis, and periodontally healthy. Periodontal clinical parameters (Probing pocket depth (PPD), Clinical attachment level (CAL), Bleeding on probing (BOP), Plaque index (PI), Gingival index (GI)) will be recorded three times: before treatment, and 6 and 12 weeks after treatment. Gingival crevicular fluid (GCF) and serum samples will be collected from participants at baseline and 12 weeks later for biochemical analysis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-04.
Trial Details
NCT Number NCT07636733
Lead Sponsor Recep Tayyip Erdogan University Training and Research Hospital
Conditions Periodontal Diseases, Gingivitis, Vitamin D Deficiency
Enrollment 120 participants
Start Date 2026-06-03
Primary Completion 2026-10-15 (estimated)
Study Completion 2026-10-16 (estimated)
Updated on ClinicalTrials.gov 2026-06-10